Cargando…
Mild Pancreatitis Induced by Linagliptin Revealed by a Medication Review
As dipeptidyl peptidase-4 inhibitors are becoming more utilized in the treatment of diabetes, it is important to recognize their side effects and become more familiar with them. As these side effects arise, physicians are more prepared to recognize and discontinue these medications. This case report...
Autores principales: | Gidda, Harish, Singh, Inderpal, Mohamed, Ayman, Nashed, Bola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116583/ https://www.ncbi.nlm.nih.gov/pubmed/37090411 http://dx.doi.org/10.7759/cureus.36455 |
Ejemplares similares
-
Vancomycin-Induced Leukocytoclastic Vasculitis: A Rare Complication From a Commonly Used Medication
por: Singh, Inderpal, et al.
Publicado: (2023) -
Acute Pancreatitis Induced by Linagliptin: A Rare but Dangerous Side Effect
por: Sharko, Artem, et al.
Publicado: (2021) -
The Forgotten Complication of Nasogastric Tube Insertion: Esophageal Perforation and Associated Hydropneumothorax and Hydropneumoperitoneum
por: Gidda, Harish, et al.
Publicado: (2023) -
Acute Viral Pericarditis Complicated by Cardiac Tamponade as a Result of COVID-19
por: Singh, Inderpal, et al.
Publicado: (2023) -
Effects of Linagliptin and Pioglitazone on Fracture Healing in an Experimental Type 2 Diabetes Rat Model
por: Mraja, Hamisi M, et al.
Publicado: (2022)